top
Search terms
Results 1 - 10 of 39 - ordered by :
Pages: 1 2 3 4
Heart

Recent clinical trials have indicated that patients with idiopathic dilated cardiomyopathy may respond differently from those with left ventricular dysfunction due to ischaemic heart disease. The ...

Heart, Editorial, R P STEEDS, K S CHANNER

Date : 01/12/1997
Ejhf

Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction ReviewAuthors Ofek Y. Hai, Division of Cardiovascular Medicine, Department of Medicine, ...

European Journal of Heart Failure, Hai, Ofek Y., Mentz, Robert J., Zannad, Faiez, Gasparini, Maurizio, De Ferrari, Gaetano M., Daubert, Jean‐Claude, Holzmeister, Johannes, Lam, Carolyn S.P., ...

Date : 01/02/2015 Item size : 237140 bytes
Ejhf

[...]clinical trials of ‘anti-inflammatory’ therapies (such as anti-tumor necrosis factor-α approaches) have to date failed to show benefit in heart failure patients. The Heart Failure ...

European Journal of Heart Failure, Heymans, Stephane, Hirsch, Emilio, Anker, Stefan D., Aukrust, Pal, Balligand, Jean‐Luc, Cohen‐Tervaert, Jan W., Drexler, Helmut, Filippatos, Gerasimos, Felix, ...

Date : 01/02/2009 Item size : 354817 bytes
Epeuropace

There is ample literature documenting an associated dyssynchrous contraction, even in patients with an otherwise normal heart.3,4 In the 1980's the first reports appeared, suggesting that left ...

Europace, HEART FAILURE, Eduardo de Teresa, Juan José Gómez-Doblas, Gervasio Lamas, Javier Alzueta, Ignacio Fernández-Lozano, Erik Cobo, Xavier Navarro, Francisco Navarro-López, Martin ...

Date : 01/06/2007 Item size : 219189 bytes
Ehjournal

Left ventricular ejection fraction is both preload and afterload dependent, can change substantially based on loading conditions, is only moderately reproducible, and represents only a single measure ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 01/06/2016 Item size : 263935 bytes
Ehjcardiovascrec

An early' G-CSF administration strategy promotes a peak of circulating progenitors 56 days after reperfusion,6 thus taking advantage of such a putative therapeutic window This hypothesis is ...

Cardiovascular Research, Letter to the Editor, S. Maggiolini, L. Lenatti, C. Malafronte, G. Pompilio, S. Righetti, F. Achilli

Date : 01/07/2011
Epeuropace

Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and ...

Europace, Implantable Cardioverter-Defibrillators, Dominic A.M.J. Theuns, Tim Smith, Myriam G.M. Hunink, Gust H. Bardy, Luc Jordaens

Date : 01/11/2010
Ehjournal

Despite state-of-the-art pharmacological and device-based treatment, the injured myocardium often appears unable to reverse massive cumulative cardiac cell death and loss of contractile ...

European Heart Journal, Janssens, Stefan P.

Date : 01/07/2011
Ehjournal

During the past three decades, considerableadvances have been made in the management of patients with coronary heart disease with beta-blockers, calcium-channel blockers, angiotensin ...

European Heart Journal, Moss, A.J.

Date : 01/01/2003 Item size : 114258 bytes
Ehjournal

[...]the EuroHeart Failure survey was conducted to ascertain if appropriate tests were being performed with which to confirm or refute a diagnosis of heart failure and how this influenced subsequent ...

European Heart Journal, Cleland, J.G.F, Swedberg, K, Follath, F, Komajda, M, Cohen-Solal, A, Aguilar, J.C, Dietz, R, Gavazzi, A, Hobbs, R, Korewicki, J, Madeira, H.C, Moiseyev, V.S, Preda, I, van ...

Date : 01/03/2003 Item size : 417681 bytes